T46.2X
Poisoning by, adverse effect of and underdosing of other antidysrhythmic drugs
Clinical Classification Guidelines
Medical Intelligence & Overview
The ICD-10 code T46.2X refers to cases of poisoning, adverse effects, or underdosing involving various antidysrhythmic medications. These drugs are used to treat irregular heart rhythms (dysrhythmias), but when misused or taken inappropriately, they can lead to serious health issues. Recognizing the risks and understanding the implications of these medications is essential for safe management and treatment.
Causes & Symptoms
Clinical Causes: Accidental overdose due to misunderstanding dosing instructions Intentional overdose in cases of self-harm or suicide attempt Adverse reactions resulting from individual sensitivity or allergies Drug interactions decreasing the effectiveness or increasing toxicity Underdosing, leading to ineffective control of arrhythmias or increased risk of toxicity Errors in medication administration by healthcare providers or patients
Key Symptoms: Dizziness or light-headedness Nausea and vomiting Confusion or mental disturbance Visual disturbances such as blurred vision Weakness or fatigue Irregular heartbeats or palpitations Signs of heart failure in severe cases Respiratory difficulties Seizures in extreme toxicity cases
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves comprehensive patient history, especially recent medication use, and clinical examination. Laboratory tests are crucial for confirming toxicity levels and evaluating organ function. Key diagnostic steps include:
Treatment Protocols: Treatment strategies aim to stabilize the patient, reduce drug toxicity, and manage symptoms. Approaches include:
Clinical Advice & FAQs
Billing Guidance
Is T46.2X a billable ICD-10 code?
Yes, T46.2X is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report T46.2X?
Clinical documentation must specify the nature of Poisoning by, adverse effect of and underdosing of other antidysrhythmic drugs and any associated comorbidities for accurate reporting.
Cite this Clinical Reference